Minireview: The diverse roles of nuclear receptors in the regulation of embryonic stem cell pluripotency

Molecular Endocrinology

Volumn 27, Issue 6, 2013, Pages 864-878

  Wagner, Ryan T ^a   Cooney, Austin J ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

GCNF; Nuclear receptors; NURSA molecule pages

Indexed keywords

CELL NUCLEUS RECEPTOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 1; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 2; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR 3; ESTROGEN RELATED RECEPTOR BETA; LIVER RECEPTOR HOMOLOG 1; MICRORNA; MICRORNA 134; MICRORNA 296; MICRORNA 470; NUCLEAR RECEPTOR DAX 1; OCTAMER TRANSCRIPTION FACTOR 4; RETINOIC ACID RECEPTOR; RETINOID; RETINOID X RECEPTOR ALPHA; RETINOID X RECEPTOR BETA; RETINOID X RECEPTOR GAMMA; STEROID RECEPTOR; STEROIDOGENIC FACTOR 1; TESTICULAR ORPHAN RECEPTOR 2; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSCRIPTION FACTOR SP1; UNCLASSIFIED DRUG;

BINDING SITE; BLASTOCYST; CELL DIFFERENTIATION; CELLULAR PARAMETERS; DISTAL ENHANCER REGION; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; EMBRYONIC STEM CELL PLURIPOTENCY; ENHANCER REGION; GENE REPRESSION; HORMONE RESPONSIVE ELEMENT; METHYLATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; PROXIMAL ENHANCER REGION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; BASE SEQUENCE; CELL PROLIFERATION; EMBRYONIC STEM CELLS; GENE EXPRESSION REGULATION; HUMANS; OCTAMER TRANSCRIPTION FACTOR-3; PLURIPOTENT STEM CELLS; PROMOTER REGIONS, GENETIC; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION;

EID: 84877889534     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/me.2012-1383     Document Type: Review

References (155)

1. Kumar V, Abbas AK, Fausto N. Robbins and Cotran Pathologic Basis of Disease. 7th Edition. 2005 Philadelphia: Elsevier Saunders.
2. Cohnheim V. Congenitales, quergestreiftes muskelsarkom der nieren. Virchows Arch Pathol Anat Physiol Klin Med. 1875: 65: 64-69.
3. Experiments on the orgin of tumors. Br Med J. 1881;2;636-637.
4. Kahan BW, Ephrussi B. Developmental potentialities of clonal in vitro cultures of mouse testicular teratoma. J Nat Cancer Inst. 1970;44:1015-1036.
5. Rosenthal MD, Wishnow RW, Sato GH. In vitro growth and differentiation of clonal populations of multipotential mouse cells derived from a transplantable testicular teratoma J Nat Cancer Inst. 1970;44:1001-1014.
6. Evans MJ. The isolation and properties of a clonal tissue culture strain of pluripotent mouse teratoma cells. J Embryol Exp Morph. 1972;28:163-176.
7. Evans MJ, Kaufman MH. Establishment in culture of pluripotential cells from mouse embryos. Nature. 1981;292:154-156.
8. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA. 1981;78(12):7634-8.
9. Thomson JA, Itskovitz-Eldor J, Shapiro SS, et al. Embryonic stem cell lines derived from human blastocysts. Science. 1998; 282: 1145-1147.
10. Labosky PA, Barlow DP, Hogan BL. Embryonic germ cell lines and their derivation from mouse primordial germ cells. Ciba Found Symp. 1994;182:157-168.
11. Labosky PA, Barlow DP, Hogan BL. Mouse embryonic germ (EG) cell lines: transmission through the germline and differences in the methylation imprint of insulin-like growth factor 2 receptor (Igf2r) gene compared with embryonic stem (ES) cell lines. Development. 1994;120(11):3197-3204.
12. Brons IG, Smithers LE, Trotter MW, et al. Derivation of pluripotent epiblast stem cells from mammalian embryos. Nature. 2007; 448:191-195.
13. Tesar PJ, Chenoweth JG, Brook FA, et al. New cell lines from mouse epiblast share defining features with human embryonic stem cells. Nature. 2007;448:196-199.
14. Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663-676.
15. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell. 2007;131:861-872.
16. Jaenisch R, Young R. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell. 2008;132:567-582.
17. Maherali N, Sridharan R, Xie W, et al. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell 2007;1:55-70.
18. Boyer LA, Lee TI, Cole MF, et al. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell. 2005;122:947-956.
19. Loh YH, Wu Q, Chew JL, et al. The Oct4 and Nanog transcription network regulates pluripotency in mouse embryonic stem cells. Nat Genet. 2006;38:431-440.
20. Masui S, Nakatake K, Toyooka Y, et al. Pluripotency governed by Sox2 via regulation of Oct3/4 expression in mouse embryonic stem cells. Nat Cell Biol. 2007;9:625-635.
21. Lee TI, Jenner RG, Boyer LA, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell 2006; 125:301-313.
22. Boyer LA, Plath K, Zeitlinger J, et al. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature. 2006;441:349-353.
23. Nichols J, Zevnik B, Anastassiadis K, et al. Formation of pluripotent stem cells in the mammalian embryo dependes on the POU transcription factor Oct4. Cell. 1998;95:379-391.
24. Avilion AA, Nicolis SK, Pevny LH, et al. Multipotent cell lineages in early mouse development depend on SOX2 function. Genes Dev. 2003;17:126-140.
25. Mitsui K, Tokuzawa Y, Itoh H, et al. The homeoprotein Nanog is required for maintenance of pluripotency in the mouse epiblast and ES cells. Cell. 113:631-642.
26. Chambers I, Silva J, Colby D, et al. Nanog safeguards pluripotency and mediates germline development. Nature 2007;450:1230-1234.
27. Chambers I, Colby D, Roberson M, et al. Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell. 2003;113:643-655.
28. Chen J, Karimi H, Archer T. Changes in attitude, changes in latitude: nuclear receptors remodeling chromatin to regulate transcription. Mol Endocrinol. 2006;20(1):1-13.
29. Lonard DM, Lanz RB, OMalley BW. Nuclear receptor coregulators and human disease. Endocr Rev. 2007;28(5):575-87.
30. Nuclear Receptor Signaling Axis on the Internet October 2010 http://www.nursa.org
31. Mangelsdorf DJ, Thummel C, Beato M, et al. The nuclear receptor superfamily: the second decade. Cell. 1995;83:835-839.
32. Donovan PJ, Gearhart J. The end of the beginning for pluripotent stem cells. Nature. 2001;414:92-97.
33. Martin GR, Evans MJ. The differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Nat Acad Sci U S A. 1975;72:1441-1445.
34. Strickland S, Mahdavi V. The induction of differentiation in teratocarcinoma stem cells by retinoic acid. Cell. 1978;15:393-403.
35. Wolbach SB, Howe PR. Tissue changes following deprivation of fat-soluble A vitamin. J Exp Med. 1925;42:753-777.
36. Wilson EL, Reich E. Plasminogen activator in chick embryo fibroblasts: induction of enzyme synthesis by retinoic acid; synergism with viral transformation and phorbol ester. Cell. 1978;15:385-392.
37. Sabella JD, Bern HA, Kahn RH. Effects of locally applied vitamin A and estrogen on rat epidermis. Proc Soc Exp Biol Med. 1951; 76:499-503.
38. Yuspa SH, Harris CC. Altered differentiation of mouse epidermal cells treated with retinyl acetate in vitro. Exp Cell Res. 1974;86: 95-105.
39. Strickland S, Smith, KK., Marotti KR. Hormonal induction of differentiation in teratocarcinoma stem cells: generation of parietal endoderm by retinoic acid and dibutyryl cAMP. Cell. 1980; 21:347-355.
40. Solter D, Shevinsky L, Knowles BB, Strickland S. The induction of antigenic changes in a teratocarcinoma stem cell line (F9) by retinoic acid. Dev Biol. 1979;70:515-521.
41. Mummery CL, Feyen A, Freund E, Shen S. Characteristics of embryonic stem cell differentiation: a comparison with two embryonal carcinoma cell lines. Cell Differ Dev. 1990;30:195-206.
42. Yeom Y, Fuhrmann G, Ovitt CE, et al. Germline regulatory element of Oct-4 specific for the totipotent cycle of embryonal cells. Development 1996;122(3):881-94.
43. Chew JL, Loh YH, Zhang W, et al. Reciprocal transcriptional regulation of Pou5f1 and Sox2 via the Oct4/Sox2 complex in embryonic stem cells. Mol Cell Biol. 2005;25:6031-6046.
44. Okumura-Nakanishi S, Saito M, Niwa H, et al. Oct-3/4 and Sox2 regulate Oct-3/4 gene in embryonic stem cells. J Biol Chem. 2005; 240:5307-5317.
45. Okazawa H, Okamoto K, Ishino F, et al. The oct3 gene, a gene for an embryonic transcription factor, is controlled by a retinoic acid repressible enhancer. EMBO J. 1991;10(10):2997-3005.
46. Umesono K, Evans RM. Determinants of target gene specificity for steroid/thyroid hormone receptors. Cell. 1989;57:1139-1146.
47. Umesono K, Murakami KK, Thompson CC, Evans RM. Direct repeats as selective response elements for the thyroid hormone, retinoic acid, and vitamin D3 receptors. Cell. 1991;65:1255-1266.
48. Pikarsky E, Sharir H, Ben-Shushan E, et al. Retinoic acid represses Oct-3/4 gene expression through several retinoic acid-responsive elements located in the promoter-enhancer region. Mol Cell Biol. 1994;14(2):1026-38.
49. Schoorlemmer J, van Puijenbroek A, van den Eijnden M, et al. Characterization of a negative retinoic acid response element in the murine Oct4 promoter. Mol Cell Biol. 1994;14(2):1122-36.
50. Sylvester I, Schöler H. Regulation of Oct-4 gene by nuclear receptors. Nucleic Acids Res. 1994;22(6):901-11.
51. Ben-Shushan E, Sharir H, Pikarsky E, Bergman Y. A dynamic balance between ARP-1/COUP-TFII, EAR-3/COUP-TFI, and retinoic acid receptor:retinoid X receptor heterodimers regulates Oct- 3/4 expresssion in embryonal carcinoma cells. Mol Cell Biol. 1995;15(2):1034-48.
52. Barnea E, Bergman Y. Synergy of SF1 and RAR in activation of Oct-3/4 promoter. J Biol Chem. 2000;275(9):6608-19.
53. Gu P, Goodwin B, Chung AC, et al. Orphan nuclear receptor LRH-1 is required to maintain Oct4 expression at the epiblast stage of embryonic development. Mol Cell Biol. 2005;25(9): 3492-505.
54. Gu P, Le Menuet D, Chung AC, et al. Orphan nuclear receptor GCNF is required for the repression of pluripotency genes during retinoic acid-induced embryonic stem cell differentiation. Mol Cell Biol. 2005;25(19):8507-19.
55. Ovitt CE, Schöler HR. The molecular biology of Oct-4 in the early mouse embryo. Mol Hum Reprod. 1998;4(11):1021-31.
56. Miura K, Okada Y, Aoi T, et al. Variation in the safety of induced pluripotent stem cell lines. Nat Biotechnol. 2009;27(8):743-5.
57. Stadtfeld M, Apostolou E, Akutsu H, et al. Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature. 2010;465:175-181.
58. Germain P, Chambon P, Eichele G, et al. International union of pharmacology. LX. Retinoic acid receptors. Pharmacol Rev. 2006;58(4):760-772.
59. Wendling O, Chambon P, Mark M. Retinoid X receptors are essential for early mouse development and placentogenesis. Proc Natl Acad Sci USA. 1999;96:547-551.
60. Jones-Villeneuve EM, Rudnicki MA, Harris JF, McBurney MW. Retinoic acid-induced neural differentiation of embryonal carcinoma cells. Mol Cell Biol. 1983;3(12):2271-2279.
61. Bain G, Ray WJ, Yao M, Gottlieb DI. Retinoic acid promotes neural and represses mesodermal gene expression in mouse embryonic stem cells in culture. Biochem Biophys Res Commun. 1996;223(3):691-694.
62. Kim M, Habbiba A, Doherty JM, et al. Regulation of mouse embryonic stem cell neural differentiation by retinoic acid. Dev Biol. 2009;328:456-471.
63. Tay YM, Tam WL, Ang YS, et al. MicroRNA-134 modulates the differentiation of mouse embryonic stem cells where is causes posttranscriptional attenuation of Nanog and LRH-1. Stem Cells. 2008;26(1):17-29.
64. Tay Y, Zhang J, Thomson AM, et al. MicroRNAs to Nanog, Oct4, and Sox2 coding regions modulate embryonic stem cell differentiation. Nature. 2008;455:1124-1128.
65. Delacroix L, Moutier E, Altobelli G, et al. Cell-specific interaction of retinoic acid receptors with target genes in mouse embryonic fibroblasts and embryonic stem cells. Mol Cell Biol. 2010;30(1): 231-244.
66. Marti E, Bovolenta P. Sonic hedgehog in CNS development: one signal, multiple outputs. Trends Neurosci. 2002;25(2):89-96.
67. Schoorlemmer J, Jonk L, Shen S, et al. Regulation of Oct-4 gene expression during differentiation of EC cells. Mol Biol Reports. 1995;21:129-140.
68. Pereira FA, Qiu Y, Zhou G, et al. The orphan nuclear receptor COUP-TFII is required for angiogenesis and heart development. Genes Dev. 1999;13(8):1037-1049.
69. Lee CT, Li L, Takamoto N, et al. The nuclear orphan receptor COUP-TFII is required for limb and skeletal muscle development. Mol Cell Biol. 2004;24(24):10835-10843.
70. Qiu Y, Pereira FA, DeMayo FJ, et al. Null mutation of mCOUPTFI results in defects in morphogenesis of the glossopharyngeal ganglion, axonal projection, and arborization. Genes Dev. 1997; 11(15):1925-1937.
71. Bardoux P, Zhang P, Flamez D, et al. Essential role of chicken ovalbumin upstream promoter-transcription factor II in insulin secretion and insulin sensitivity revealed by conditional gene knockout. Diabetes. 2005;54(5):1357-1363.
72. Xu Z, Yu S, Hsu CH. The orphan nuclear receptor chicken ovalbumin upstream promoter-transcription factor II is a critical regulator of adipogenesis. Proc Natl Acad Sci USA. 2008;105(7):2421-2426.
73. Pereira FA, Qiu Y, Tsai MJ, Tsai SY. Chicken ovalbumin upstream promoter transcription factor (COUP-TF): expression during mouse embryogenesis. J Steroid Biochem Mol Biol. 1995;53: 503-508.
74. Naka H, Nakamura S, Shimazaki T, Okano H. Requirement for COUP-TFI and II in the temporal specification of neural stem cells in CNS development. Nat Neurosci. 2008;11(9):1014-1023.
75. Lee CH, Chang L, Wei LN. Molecular cloning and characterization of a mouse nuclear orphan receptor expressed in embryos and testes. Mol Reprod Dev. 1996;44(3):305-314.
76. Lee CH, Chang L, Wei LN. Dictinct expression patterns and biological activities of two isoforms of the mouse orphan receptor TR2. J Endocrinol. 1997;152(2):245-255.
77. Lee YF, Lee HJ, Chang C. Recent advances in the TR2 and TR4 orphan receptors of the nuclear receptor superfamily. J Steroid Biochem Mol Biol. 2002;81:291-308.
78. Lee CH, Chinpaisal C, Wei LN. Cloning and characterization of mouse RIP140, a corepressor for nuclear orphan receptor TR2. Mol Cell Biol. 1998;18(11):6745-6755.
79. Park SW, Hu X, Gupta P, et al. SUMOylation of Tr2 orphan receptor involves Pml and fine-tunes Oct4 expression in stem cells. Nat Struct Mol Biol. 2007;14(1):68-75.
80. Gupta P, Ho PC, Huq MM, et al. Retinoic acid-stimulated sequential phosphorylation, PML recruitment, and SUMOylation of nuclear receptor TR2 to suppress Oct4 expression. Proc Natl Acad Sci USA. 2008;105:11424-11429.
81. Shyr CR, Collins LL, Mu XM, et al. Spermatogenesis and testis development are normal in mice lacking testicular orphan nuclear receptor 2. Mol Cell Biol. 2002;22:4661-4666.
82. Lee MB, Lebedeva LA, Suzawa M, et al. The DEAD-box protein DP103 (Ddx20 or Gemin-3) represses orphan nuclear receptor activity via SUMO modification. Mol Cell Biol. 2005;25(5): 1879-1890.
83. Wagner RT, Cooney AJ. Oct4: less is more. Cell Res. 2009;19(5): 527-528.
84. Chung AC, Katz D, Pereira FA, et al. Loss of orphan receptor germ cell nuclear factor function results in ectopic development of the tail bud and novel posterior truncation. Mol Cell Biol. 2001;21: 663-677.
85. Süsens U, Aguiluz JB, Evans RM, Borgmeyer U. The germ cell nuclear factor mGCNF is expressed in the developming nervous system. Dev Neurosci. 1997;19:410-420.
86. Katz D, Niederberger C, Slaughter GR, Cooney AJ. Characterization of germ cell-specific expression of the orphan nuclear receptor, germ cell nuclear factor. Endocrinology. 1997;138:4364-4372.
87. Fuhrmann G, Chung AC, Jackson K, et al. Mouse germline restriction of Oct4 expression by germ cell nuclear factor. Dev Cell. 2001;1(3):377-387.
88. Lan ZJ, Chung AC, Xu X, et al. The embryonic function of germ cell nuclear factor is dependent on theDNAbinding domain. J Biol Chem. 2002;277(52):50660-50667.
89. Yan Z, Jetten AM. Characterization of the repressor function of the nuclear orphan receptor retinoid receptor-related testis-associated receptor/germ cell nuclear factor. J Biol Chem. 2000; 275(45):35077-35085.
90. Gu P, Morgan DH, Sattar M, et al. Evolutionary trace-based peptides identify a novel asymmetric interaction that mediates oligomerization in nuclear receptors. J Biol Chem. 2005;280(36): 31818-31829.
91. Gu P, Xu X, Le Menuet D, Chung AC, Cooney AJ. Differential recruitment of methyl CpG-binding factors and DNA methyltransferases by the orphan receptor germ cell nuclear factor initiates the repression and silencing of Oct4. Stem Cells. 2011;29(7): 1041-1051.
92. Sato N, Kondo M, Arai K. The orphan nuclear receptor GCNF recruits DNA methyltransferase for Oct-3/4 silencing. Biochem Biophys Res Commun. 2006;344(3):845-851.
93. Kaji K, Caballero IM, MacLeod R, et al. The NuRD component of Mbd3 is required for pluripotency of embryonic stem cells. Nat Cell Biol. 2006;8(3):285-292.
94. Okano M, Bell DW, Haber DA, et al. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylationand mammalian development. Cell. 1999;99:247-257.
95. Chen T, Ueda Y, Dodge JE, et al. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol Cell Biol. 2003;23(16): 5594-5605.
96. Li JY, Pu MT, Hirasawa R, et al. Synergistic function of DNA methyltransferases Dnmt3a and Dnmt3b in the methylation of Oct4 and Nanog. Mol Cell Biol. 2007;27(24):8748-8759.
97. Heng JC, Feng B, Han J, et al. The nuclear receptor Nr5a2 can replace Oct4 in the reprogramming of murine somatic cells to pluripotent cells. Cell Stem Cell. 2010;6(2):167-174.
98. Feng B, Jiang J, Kraus P, et al. Reprogramming of fibroblasts into induced pluripotent stem cells with orphan nuclear receptor Esrrb. Nat Cell Biol. 2009;11(2):197-203.
99. Fayard E, Auxerx J, Schoonjans K. LRH-1: an orphan nuclear receptor involved in development, metabolism, and steroidogenesis. Trends Cell Biol. 2004;14(5):250-260.
100. Luo X, Ikeda Y, Lala DS, et al. A cell-specific nuclear receptor plays essential roles in adrenal and gonadal development. Endocr Res. 1995;21:517-524.
101. Pare JF, Malenfant D, Couremanche C, et al. The fetoprotein transcription factor (FTF) gene is essential to embryogenesis and cholesterol homeostasis and is regulated by a DR4 element. J Biol Chem. 2004;279:21206-21216.
102. Hinshelwood MM, Repa JJ, Shelton JM, et al. Expression of LRH-1 and SF-1 in the mouse ovary: localization in different cell types correlates with differing function. Mol Cell Endocrinol. 2003;207:39-45.
103. Ikeda Y, Lala DS, Luo X, et al. Characterization of the mouse FTZ-F1 gene which encodes a key regulator of steroid hydroxylase gene expression. Mol Endocrinol. 1993;7(7):852-860.
104. Ingraham HA, Lala DS, Ikeda Y, et al. The nuclear receptor steroidogenic factor-1 acts at multiple levels of the reproductive axis. Genes Dev. 1994; 8(19):2302-2312.
105. Sun C, Nakatake Y, Ura H, et al. Stem cell-specific expression of Dax1 is conferred by STAT3 and Oct3/4 in embryonic stem cells. Biochem Biophys Res Commun. 2008;372:91-96.
106. Crawford PA, Sadovsky Y, Milbrandt J. Nuclear receptor steroidogenic factor-1 directs embryonic stem cells toward the steroidogenic lineage. Mol Cell Biol. 1997;17(7):3997-4006.
107. Labelle-Dumais C, Jacob-Wagner M, Pare JF, et al. Nuclear receptor NR5A2 is required for proper primitive streak morphogenesis. Dev Dyn. 2006;235:3359-3369.
108. Wagner RT, Xu X, Yi F, et al. Canonical Wnt/catenin regulation of liver receptor homolog-1 (Lrh-1) mediates pluripotency gene expression. Stem Cells. 2010;28(10):1794-1804.
109. Zhou Q, Chipperfield H, Melton DA, Wong WH. A gene regulatory network in mouse embryonic stem cells. Proc Natl Acad Sci USA. 2007;104:16438-16443.
110. Haegel H, Larue L, Ohsugi M, et al. Lack of _-catenin affects mouse development at gastrulation. Development. 1995;121: 3529-3537.
111. Korinek V, Barker N, Moerer P, et al. Depletion of epithelial stem-cell compartments in the small intestine of mice lacking Tcf-4. Nat Genet. 1998;19:379-383.
112. Reya T, Duncan AW, Ailles L, et al. A role for Wnt signaling in self-renewal of haematopoietic stem cells. Nature. 2003;423:409-414.
113. Sato N, Meijer L, Skaltsounis L, et al. Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med. 2004;10:55-63.
114. Ogawa K, Nishinakamura R, Iwamatsu Y, et al. Synergistic action of Wnt and LIF in maintaining pluripotency of mouse ES cells. Biochem Biophys Res Commun. 2006;343:159-166.
115. Cai L, Ye Z, Zhou BY, et al. Promoting human embryonic stem cell renewal or differentiation by modulating Wnt signal and culture conditions. Cell Res. 2007;17:62-72.
116. Gao DM, Wang LF, Liu J, et al. Expression of mouse liver receptor homologue 1 in embryonic stem cells is directed by a novel promoter. FEBS Lett. 2006;580:1702-1708.
117. Niwa H, Ogawa K, Shimosato D, et al. A parallel circuit of LIF signaling pathways maintains pluripotency of mouse ES cells. Nature. 2009;460:118-122.
118. Stewart CL, Kaspar P, Brunet LJ, et al. Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature. 1992; 359:76-79.
119. Nichols J, Chambers I, Taga T, et al. Physiological rationale for responsiveness of mouse embryonic stem cells to gp130 cytokines. Development. 2001;128:2333-2339.
120. Ying QL, Wray J, Nichols J, et al. The ground state of embryonic stem cell self-renewal. Nature. 2008;453:519-523.
121. Silva J, Nichols J, Theunissen TW, et al. Nanog is the gateway to the pluripotent ground state. Cell. 2009;138:722-737.
122. Guo G, Yang J, Nichols J, et al. Klf4 reverts developmentally programmed restriction of ground state pluripotency. Development 2009;136:1063-1069.
123. Yang J, van Oosten AL, Theunissen TW, et al. Stat3 activation is limiting for reprogramming to ground state pluripotency. Cell Stem Cell. 2010;7:319-328.
124. Guo G, Smith A. A genome-wide screen in EpiSCs identifies Nr5a nuclear receptors as potent inducers of ground state pluripotency. Development. 2010;137:3185-3192.
125. Lalli E, Sassone-Corsi P. DAX-1, an unusual orphan receptor at the crossroads of steroidogenic function and sexual differentiation. Mol Endocrinol. 2003;17:1445-1453.
126. Lalli E, Bardoni B, Zazopoulos E, et al. A transcriptional silencing domain in DAX-1 whose mutation causes adrenal hypoplasia congenital. Mol Endocrinol. 11:1950-1960.
127. Swain A, Narvaez V, Burgoyne P, et al. Dax1 antagonizes Sry action in mammalian sex determination. Nature. 1998;391:761-767.
128. Zanaria E, Muscatelli F, Bardoni B, et al. An unusual member of the nuclear hormone receptor superfamily responsible for X-linked adrenal hypoplasia congenita. Nature. 1994;372:635-641.
129. Muscatelli F, Strom TM, Walker AP, et al. Mutations in the DAX-1 gene give rise to both X-linked adrenal hypoplasia congenita and hypogonadotropic hypogonadism. Nature. 1994;372: 672-676.
130. Clipsham R, Niakan K, McCabe ER. Nr0b1 and its network partners are expressed early in murine embryos prior to steroidogenic axis organogenesis. Gene Expr Patterns. 2004;4:3-14.
131. Niakan KK, Davis EC, Clipsham RC, et al. Novel role for the orphan nuslear receptor Dax1 in embryogenesis, different from steroidogenesis. Mol Genet Metab. 2006;88:261-271.
132. Lee JM, Lee YK, Mamrosh JL, et al. A nuclear-receptor-dependent phosphatidylcholine pathway with antidiabetic effects. Nature. 2011;474:506-510.
133. Sun C, Nakatake Y, Ura H, et al. Stem cell-specific expression of Dax1 is conferred by STAT3 and Oct3/4 in embryonic stem cells. Biochem Biophys Res Commun. 2008;372:91-96.
134. Wang J, Rao S, Chu J, et al. A protein interaction network for pluripotency of embryonic stem cells. Nature. 2006;444:364-368.
135. Kim J, Chu J, Shen X, et al. An extended transcriptional network for pluripotency of embryonic stem cells. Cell. 2008;132:1049-1061.
136. Sun C, Nakatake Y, Akagi T, et al. Dax1 binds to Oct3/4 and inhibits its transcriptional activity in embryonic stem cells. Mol Cell Biol. 2009;29:4574-4583.
137. van den Berg DL, Snoek T, Mullin NP, et al. An Oct4-centered protein interaction network in embryonic stem cells. Cell Stem Cell. 2010;6:369-381.
138. Giguere V, Yang N, Segui P, Evans RM. Identification of a new class of steroid hormone receptor. Nature. 1988;331:91-94.
139. Ariazi EA, Jordan VC. Estrogen-related receptors as emerging targets in cancer and metabolic disorders. Curr Top Med Chem. 2006;6:203-215.
140. Pettersson K, Svensson K, Mattsson R, et al. Expression of a novel member of estrogen response element-binding nuclear receptors is restricted to the early stages of chorion formation during mouse embryogenesis. Mech Dev. 54:211-223.
141. Luo J, Sladek R, Bader JA, et al. Placental abnormalities in mouse embryos lacking the orphan nuclear receptor ERR-_. Nature. 1997;388:778-782.
142. Mitsunaga K, Araki K, Mizusaki H, et al. Loss of PGC-specific expression of the orphan nuclear receptor ERR-_ results in reduction of germ cell number in mouse embryos. Mech Dev. 2004;121: 237-246.
143. Ivanova N, Dobrin R, Lu R, et al. Dissecting self-renewal in stem cells with RNA interference. Nature. 2006;442:533-538.
144. Suetsugi M, Su L, Karlsberg K, et al. Flavone and isoflavone phytoestrogens are agonists of estrogen-related receptors. Mol Cancer Res 2003;1:981-991.
145. van den Berg DL, Zhang W, Yates A, et al. Estrogen-related receptor _ interacts with Oct4 to positively regulate Nanog gene expression. Mol Cell Biol. 2008;28:5986-5995.
146. Storm MP, Bone HK, Beck CG, et al. Regulation of Nanog expression by phosphoinositide 3-kinase-dependent signaling in murine embryonic stem cells. J Biol Chem. 282:6265-6273.
147. Zhang X, Zhang J, Wang T, et al. Esrrb activates Oct4 transcription and sustains self-renewal and pluripotency in embryonic stem cells. J Biol Chem. 2008;283:35825-35833.
148. Zwaka TP, Thomson JA. A germ cell origin of embryonic stem cells? Development. 2005;132:227-233.
149. Festuccia N, Osorno R, Halbritter F, et al. Esrrb is a direct Nanog target gene that can substitute for Nanog function in pluripotent cells. Cell Stem Cell 2012;11(4):477-490.
150. Martello G, Sugimoto T, Diamanti E, et al. Esrrb is a pivotal target of the Gsk3/Tcf3 axis regulating embryonic stem cell self-renewal. Cell Stem Cell. 2012;11(4): 491-504.
151. Xie CQ, Jeong Y, Fu M, et al. Expression profiling of nuclear receptors in human and mouse embryonic stem cells. Mol Endocrinol. 2009;23:724-733.
152. Yu J, Hu K, Smuga-Otto K, et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science. 2009;324: 797-801.
153. Kim D, Kim CH, Moon JL, et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell. 2009;4:472-476.
154. Woltjen K, Michael IP, Mohseni P, et al. Piggy Bac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature. 2009;458:766-770.
155. Whitby RJ, Dixon S, Maloney PR, et al. Identification of small molecule agonists of the orphan nuclear receptors liver receptor homolog-1 and steroidogenic factor-1. J Med Chem. 2006;49:6652-6655.